Holen Sie sich die Stockscreener-App
29.59
1.17%
-0.35
Handel nachbörslich:
29.10
-0.49
-1.66%
Edgewise Therapeutics Inc Aktie (EWTX) Neueste Nachrichten
Edgewise’s New EDG-7500 Study Signals Broader Cardiovascular Ambitions - TipRanks
A Look At Edgewise Therapeutics (EWTX) Valuation After Encouraging Long Term Sevasemten Becker Data - simplywall.st
Edgewise Therapeutics Completes Key Renal Study for EDG-7500, Setting Up Next Steps for Investors - TipRanks
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
EWTX: 7500 advances toward Phase III in HCM, with Becker data showing disease stabilization - TradingView
American Century Companies Inc. Buys 312,307 Shares of Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Edgewise reports functional stability in Becker dystrophy trial By Investing.com - Investing.com Canada
Raymond James reiterates Strong Buy on Edgewise Therapeutics stock after trial data - Investing.com Canada
Truist reiterates Edgewise Therapeutics stock rating on trial data - Investing.com India
Edgewise reports functional stability in Becker dystrophy trial - Investing.com Nigeria
Truist reiterates Edgewise Therapeutics stock rating on trial data By Investing.com - Investing.com Canada
Edgewise Announces Positive Long-Term Sevasemten Data Demonstrating Sustained Functional Stabilization in Becker Muscular Dystrophy Through 3.5 Years of Follow-Up - PR Newswire
Will Edgewise Therapeutics Inc stock recover after earningsPortfolio Return Report & Long-Term Capital Growth Ideas - baoquankhu1.vn
EPS Watch: Will Edgewise Therapeutics Inc stock hit new highs in YEAR2026 Highlights & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Trading Systems Reacting to (EWTX) Volatility - Stock Traders Daily
Vanguard Group Inc. Has $77.92 Million Stake in Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Aug PreEarnings: Is Edgewise Therapeutics Inc being accumulated by smart money2025 Valuation Update & Daily Stock Momentum Reports - baoquankhu1.vn
Edgewise Therapeutics, Inc. (EWTX) Stock Price, News, Quote & History - Yahoo Finance
Edgewise Therapeutics to Present at Leerink Global Healthcare Conference on March 11, 2026 - geneonline.com
Edgewise Therapeutics to Present at the Leerink Global Healthcare Conference on March 11, 2026 - Yahoo Finance
Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Unpacking A 35.24% Upside Potential - DirectorsTalk Interviews
Edgewise Therapeutics Reports Inducement Grants as Permitted by the Nasdaq Listing Rules - 富途牛牛
Edgewise Therapeutics to Present on Sevasemten for the Treatment of Becker Muscular Dystrophy at the 2026 MDA Clinical and Scientific Conference - PR Newswire
EWTX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Edgewise Therapeutics (EWTX) Is Down 6.8% After Wider 2025 Losses And New BMD Data Plans – Has The Bull Case Changed? - Sahm
Edgewise Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Three new Edgewise hires get options to buy 51,000 shares - Stock Titan
Citigroup Inc. Sells 186,446 Shares of Edgewise Therapeutics, Inc. $EWTX - MarketBeat
FY2026 Earnings Forecast for EWTX Issued By HC Wainwright - MarketBeat
Investor Mood: Will Edgewise Therapeutics Inc stock hit new highs in YEARJuly 2025 Trade Ideas & AI Based Buy/Sell Signal Reports - baoquankhu1.vn
Aug Reactions: Is Edgewise Therapeutics Inc stock forming a cup and handleTrade Exit Report & Community Verified Watchlist Alerts - baoquankhu1.vn
Artisan Partners Limited Partnership Reduces Stake in Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Edgewise Therapeutics (NASDAQ:EWTX) Stock Rating Upgraded by HC Wainwright - MarketBeat
Assessing Edgewise Therapeutics (EWTX) Valuation As Earnings And Key Clinical Milestones Draw Closer - simplywall.st
Edgewise Therapeutics (NASDAQ:EWTX) Downgraded to Sell Rating by Wall Street Zen - MarketBeat
Evercore Maintains Outperform, PT $45 for Edgewise Therapeutics (EWTX) Feb 2026 - Meyka
Q1 Earnings Estimate for EWTX Issued By HC Wainwright - MarketBeat
Edgewise Therapeutics (NASDAQ:EWTX) Posts Earnings Results - MarketBeat
Evercore ISI raises Edgewise Therapeutics price target on HCM data By Investing.com - Investing.com Canada
Raymond James reiterates Strong Buy on Edgewise Therapeutics stock By Investing.com - Investing.com Canada
Raymond James reiterates Strong Buy on Edgewise Therapeutics stock - Investing.com UK
Edgewise Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Edgewise Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Stifel raises Edgewise Therapeutics stock price target on trial data timeline - Investing.com Canada
Edgewise Therapeutics Q4 Net Loss Widens From Previous Quarter - marketscreener.com
Earnings Flash (EWTX) Edgewise Therapeutics Posts Q4 Net Loss $0.47 a Share, vs. FactSet Est of $0.40 Loss - marketscreener.com
Edgewise Therapeutics, Inc. SEC 10-K Report - TradingView
Assessing Edgewise Therapeutics (EWTX) Valuation After Strong Multi‑Year Returns And Recent Share Price Momentum - Yahoo Finance
Edgewise Therapeutics Q4 net loss widens vs Q3 as costs rise - TradingView
Edgewise (Nasdaq: EWTX) ups R&D spending as Q4 2025 loss widens - Stock Titan
BRIEF-Edgewise Therapeutics Q4 Operating Income USD -55.979 Million - TradingView
Edgewise Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results with Strong Progress Across Muscular Dystrophy and Cardiovascular Programs - PR Newswire
Edgewise Therapeutics stock hits 52-week high at $31.39 By Investing.com - Investing.com India
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):